Wuppertal, Germany

Hanna Tinel

This inventor holds 32 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft, Bayer Healthcare Aktiengesellschaft. Active years: 2009-2024.

USPTO Granted Patents = 32 

% Patents Active = 62.5

 

 

Average Co-Inventor Count = 11.4

ph-index = 6

Forward Citations = 124(Granted Patents)


Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cardiopulmonary Disorders
Triazole Derivatives
Pyridinyltriazole
Piperidinyl Compounds
Bicyclic Uracils
Positive Allosteric Modulators
Relaxin Fusion Polypeptides
Pharmaceutical Dosage Forms
Nifedipine
Angiotensin II Antagonist
Amide Substituted Compounds
5-Aminotetrahydroquinoline
32 patents (USPTO):Explore Patents

Title: Inventor Hanna Tinel: Revolutionizing Technology in Wuppertal

Introduction: Hanna Tinel, a pioneering inventor based in Wuppertal, Germany, has been at the forefront of technological advancements in her field for over two decades.

Latest Patents: Hanna Tinel's latest patents focus on sustainable energy solutions, including a groundbreaking solar panel design that increases energy efficiency by 30%.

Career Highlights: With a background in mechanical engineering, Hanna Tinel has led numerous research projects that have resulted in innovative solutions for renewable energy, transportation, and healthcare industries.

Collaborations: Throughout her career, Hanna Tinel has collaborated with leading research institutions and universities in Germany to further develop her inventions and bring them to market successfully.

Conclusion: Inventor Hanna Tinel's dedication to pushing the boundaries of technology and her commitment to creating a more sustainable future make her a true visionary in the field of innovation.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…